Currently, bone scan, computed tomography (CT), and magnetic resonance imaging (MRI) are commonly used in staging of PCa.7National Comprehensive Cancer Network guidelines consider prostate-specific membrane antigen (PSMA) ligand positron emission tomography/computed tomography (PET/CT) as “equally effective, if not more effective compared to conventional imaging” for initial staging of PCa. The gene discussed is FOLH1; the disease is posterior cortical atrophy.